This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Aging Advisory Panel of the Endocrine Society (2001) Report of National Institute on Aging Advisory Panel on Testosterone Replacement in men. J Clin Endocrinol Metab 86: 4611
Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB (1998) The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 60: 458–465
Aversa A, Isodori AM, Spera G, Lenzi A, Fabbri A (2003) Androgens improve cavernous vasodilatation and response to sildenafil in patients with ED. Clin Endocrinol 58: 632
Bartsch G, Rittmaster RS, Klocher H (2000) Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostataic hyperplasia. Eur Urol 37: 367
Beutel ME, Wiltink J, Schwarz R, Weidner W, Brähler E (2002) Complaints of the aging male based on a representative community study. Eur Urol 41: 85
Blanker MH, Driessen LFC, Bosch JLHR et al. (2002) Health status and its correlates among dutch community-dwelling older men with and without lower urogenital tract dysfunction. Eur Urol 41: 602
Bodie J, Lewis J, Schow D, Monga M (2003) Laboratory evaluations of erectile dysfunction: an evidence based approach. J Urol 169: 2262–2264
Brähler E, Merbach M (2004) Warum sterben Männer früher? Psychomed 16: 3–7
Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U (2000) Epidemiology of erectile dysfunction: results of the Cologne Male Survey. Int J Impotence Res 12: 305–311
Burger B, Weidner W, Altwein J (1999) Prostate and sexuality: an overview. Eur Urol 35: 177–184
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and it’s medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151: 54
Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30: 328–338
Feldman HA, Longcope C, Derby CA et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the MMAS. J Clin Endocrinol Metab 87: 589
Goldstein I (2000) The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. Am J Cardiol 86: 41F–45F
Gruenewald DA, Matsumoto AM (2003) Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 51: 101
Hajjar RR, Kaiser FE, Morley JE (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 82: 3793
Hargreave TB, Meulemann EJW, Weidner W (2004) Hormonal replacement therapy for aging men? Eur Urol 46: 155
Härkönen K. Huhtaniemi I, Mäkinen J et al. (2003) The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26: 187
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86: 729
Hauri D (2003) Erectile dysfunction in the elderly man. Urol Int 70: 89–99
Heinemann LA, Saad F, Thile K, Wood-Dauphinee S (2001) The aging males symptoms rating scale: cultural and linguistic validation into english. Aging Male 4: 14–22
Hoffmann MA, DeWolf WC, Morgentaler A (2000) Is low serum free testosterone a marker for high grade prostate cancer? J Urol 163: 824
Huggins CB, Stevens RB, Hodges CV (1941) The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 43: 209
Ito K, Yamamoto T, Ohi M, Takechi H, Kurokawa K, Suzuki K, Yamanaka H (2003) Possibility of re-screening intervals of more than one year in PSA-levels of 4 ng/ml or less. Prostate 57: 8
Jain P, Rademacher AW, Mc Vary KT (2000) Testosterone supplementation for erectile dysfunction: results of meta-analysis. J Urol 164: 371–375
Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, Mc Kinlay JB (2000) Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 163: 460–463
Jung A, Schuppe HC, Schill W-B (2003) Are children of older fathers at risk for genetic disorders? Andrologia 35: 191
Kaufmann JM, T’Sjoen G (2002) The effects of testosterone deficiency on male sexual dysfunction. Aging Male 5: 242–247
Kaufman JM, Zmierczak H, Goemaere S (2001) Osteoporosis in the aging population: the male perspective. Aging Male 4: 62–73
Khaw KT, Bingham S, Welch A et al. (2001) Relation between plasma ascorbic acid and mortality in men and woman in EPIC-Norfolk prospective study: a prospective population study. Lancet 357: 657–663
Kirkwood TB, Austad SN (2000) Why do we age? Nature 408: 233
Kucuk O (2002) Chemoprevention of prostate cancer. Cancer Metastasis Rev 21: 111–124
Lawrence JS It, Madakasira S (1992) Evaluation and treatment of premature ejaculation: a critical review. Int J Psychatry Med 22: 77–97
Martin GM, Austad SN, Johson TE (1996) Genetic analysis of ageing: role of oxidative damage and environment stresses. Nat Genet 13: 25
Martinez Portillo FJ, Jünemann K-P (2003) Operative Therapie der erektilen Dysfunktion. Aktueller Stand. Urologe A 42: 1337–1344
Massengill JC, Sun L, Moul JW et al. (2003) Pretreatment total testosterone levels predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169: 1670
Matsumoto AM (2002) Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol 571: M76
Melton LJ, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BJ (1998) Bone density and fracture risk in men. J Bone Miner Res 13: 1915–1923
Merbach M, Brähler E (2004) Psychosoziale Faktoren des Alterns. In: Schill W, Bretzel R, Weidner W (Hrsg) MännerMedizin. Urban & Fischer, München, S 25–29
Moncada J (2003) Luts: a risk factor for sexual dysfunction in the BPH patient. Eur Urol (Suppl) 2: 3–8
Morales A (2002) Androgen replacemant therapy and prostate safety. Eur Urol 41: 113
Morales A, Lunenfeld B (2001) Androgen replacement therapy in aging men with secondary hypogonadism. Draft of recommendations for endorsement of ISSAM. Aging Male 4: 151–162
Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Official Recommendation of ISSAM Aging Male 5: 74
Morales A, Tenover JL (2002) Androgen deficiency in the aging male: when, who and how to investigate and treat. Urol Clin North Am 29: 975
Morgentaler A, Bruning CO, DeWolf WC (1996) Occult prostate cancer in men with low serum testosterone levels. JAMA 276: 1904
Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCrady D, Perry HM (2000) Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49: 1239
Nawrot TS, Staessen JA, Garnder JP, Aviv A (2004) Telomere length and possible links to X-chromosome. Lancet 363: 507
Nomura A, Heilbrun LK, Stemmernicen GN, Judd HL (1988) Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res 48: 3515
Rhoden EL, Morgentaler A (2003) Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. J Urol 170: 2348
Rhoden EL, Teloken C, Mafessoni R, Vagas Souto CA (2002) Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction. Int J Impotence Res 14: 167
Rosen RC (2003) Looking beyond erectile dysfunction: the need for multi-dimensional assessment of sexual dysfunction. Eur Urol (Suppl 2): 9–12
Rosen RC, Altwein J, Boyle B et al. (2003) Lower urinary tract symptoms and male sexual dysfunction: the Multi-National Survey of the Aging Male (MSAM — 7). Eur Urol 44: 637
Schatzl G, Madersbacher St, Haitel A et al. (2003) Associations of serum testosterone with microvessel density, androgen receptor gene polymorphism in prostate cancer. J Urol 169: 1312
Seftel AD (2003) Erectile dysfunction in the elderly: epidemiology, etiology and approaches to the treatment. J Urol 169: 1999–2007
Semler J (1998) Die Osteoporose des Mannes. Osteologie 7(Suppl 1): 103–134
Shabsigh R, Kaufmann JM, Steidle C, Radma-Nathan H (2004) Randomized study of testosterone gel as adjunetive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172: 658
Smith KW, Feldman HA, McKinley JB (2000) Construction and field validation of a self-administered screener for testosterone deficiency in ageing men. Clin Endocrinol (Oxf) 53: 703
Tenover JL (1997) Androgen administation to aging men. Endocrinol Metab Clin North Am 23: 877
Vaupel, JW, Carey JR, Christensen K (1998) Biodemographic trajectories of longevity. Science 280: 855
Veldhuis JD (1997) Elements in the pathophysiology of diminished growth hormone (GH) secretion in aging humans. Endocrine 7: 41
Vermeulen A, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free hormones in serum. J Clin Endocrinol Metab 84: 3666
Vermeulen A, Kaufmann JM (2002) Diagnosis of hypogonadism in the aging male. Aging Male 5: 170
Weidner W (2003) Erektile Dysfunktion — ein Dauerbrenner. Was ist wirklich neu an Diagnostik und Therapie? Urologe A 42: 1315–1316
Weidner W, Altwein J, Hauck E, Beutel M, Brähler E (2001) Sexuality of the elderly. Urol Int 66: 181
Weidner W, Diemer T, Bergmann M (2002) Infertility in the elderly. In: Lunenfeld B, Gooren J (eds) Textbook of men’s health. Parthenon, Bora Raton, London New York, pp 97–103
Werner AA (1946) The male climacteric. J Am Med Assoc 132: 188
Wilson GT, Niaura RS, Adler JL (1985) Alcohol, selective attention and sexual arousal in men. J Stud Alcohol 45: 107–115
Yoshizawa K, Willett WC, Morris SJ (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90: 1219–1224
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Weidner, W. (2006). Altershypogonadismus. In: Facharztwissen Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-32986-2_10
Download citation
DOI: https://doi.org/10.1007/3-540-32986-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-20009-3
Online ISBN: 978-3-540-32986-2
eBook Packages: Medicine (German Language)